Intuitive Surgical INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
Intuitive Surgical achieved significant revenue and procedure growth in 2025, fueled by strong adoption of its da Vinci surgical systems, particularly the new da Vinci 5, and expanding use of the Ion endoluminal system.
NASDAQ
10-K: Intuitive Surgical Reports Strong 2024 Growth, Driven by Procedure Volume and System Placements
Intuitive Surgical's 2024 10-K filing reveals a robust year marked by significant revenue growth, increased procedure volumes, and strategic advancements in its product offerings.
NASDAQ
Intuitive Surgical's 10-K filing details its extensive subsidiary network, business strategy focused on minimally invasive care, and the competitive landscape it operates within.